Physician

Derrick Wong, M.D.

According to 2025 Medicare claims, Derrick Wong, M.D. (NPI: 1194941104) practices hematology/oncology in the San Jose-Sunnyvale-Santa Clara, CA market, with the plurality of this provider's patient population coming from Santa Clara, CA. This provider's primary affiliated billing organization is SUTTER BAY MEDICAL FOUNDATION (NPI: 1013950807; TIN: 941156581) and primary practice location at 94086-6386. Wong is affiliated with the Sutter Medicare Direct (ACO ID: A5279), participating under the MSSP model.

Wong's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 905 traditional Medicare patients, billed 161,982 HCPCS/CPT codes, and received $3,147,609 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 1,320 prescription claims across 235 beneficiaries totaling $5,287,485 in drug costs, led by Brukinsa (Zanubrutinib). DME data shows 44 claims. Open Payments data shows 1 records totaling $17. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $1,603,555 and ending at $3,147,609. Concurrently, Part D prescription costs have risen steadily, from $674,007 to $5,287,485. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	726	126,139	$1,603,555
2016	808	188,305	$2,966,401
2017	783	133,253	$2,836,333
2018	838	228,181	$4,255,002
2019	831	178,520	$3,275,829
2020	713	129,348	$2,374,646
2021	827	143,670	$2,962,516
2022	836	211,841	$3,914,120
2023	851	193,143	$3,198,282
2024	905	161,982	$3,147,609

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	146	952	$674,007
2016	175	1,260	$1,068,912
2017	192	1,432	$2,017,475
2018	200	1,372	$2,577,639
2019	202	1,363	$2,787,408
2020	208	1,215	$3,320,765
2021	212	1,273	$4,257,447
2022	224	1,298	$4,743,494
2023	213	1,310	$4,745,219
2024	235	1,320	$5,287,485

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	22	$2,625
2016	N/R	85	$8,846
2017	N/R	67	$5,120
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	16	$306
2021	N/R	14	$269
2022	N/R	29	$966
2023	N/R	33	$926
2024	N/R	44	$1,187

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	273	771	$164
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	287	397	$109
96365	Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less	125	260	$66
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	343	545	$15
J7050	Infusion, normal saline solution, 250 cc	168	293	$1

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Brukinsa	Zanubrutinib	38	1,140	$572,856
Pomalyst	Pomalidomide	26	728	$562,466
Revlimid	Lenalidomide	28	772	$514,199
Tagrisso	Osimertinib Mesylate	31	930	$503,168
Lenalidomide	Lenalidomide	35	970	$451,339

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J8521	Capecitabine, oral, 500 mg	N	N/R	11	$427
J8530	Cyclophosphamide; oral, 25 mg	N	N/R	13	$383
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	N/R	20	$376

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	1	$17	Daiichi Sankyo Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Derrick Wong, M.D.?

Tedicare shows public-source Medicare data for Derrick Wong, M.D. (NPI 1194941104), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Derrick Wong, M.D. have ACO affiliation data?

Derrick Wong, M.D. is shown with ACO affiliation data for Sutter Medicare Direct (MSSP, ACO ID A5279).

What billing organization is linked to Derrick Wong, M.D.?

Derrick Wong, M.D. is linked to SUTTER BAY MEDICAL FOUNDATION (billing NPI 1013950807) in the available physician profile data.

Does Derrick Wong, M.D. have Open Payments data?

Derrick Wong, M.D. has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.